Idiopathic Calcium Oxalate Urolithiasis and Endogenous Oxalate Production

References

• Michell A R. Urolithiasis-historical, comparative and pathophysiological aspects: A review. J R Soc Med 1989; 82: 669–72
   PubMed Web of Science ®Google Scholar
• Van Aswegen C H, Du Plessis D J. A biochemical approach to renal stone formation. Adv Clin Chem 1992; 29: 263–72
   PubMedGoogle Scholar
• Menon M, Koul H. Clinical review 32: Calcium oxalate nephrolithiasis. J Clin Endocrinol Metab 1992; 74: 703–7
   PubMedGoogle Scholar
• Robertson W G. Urinary tract calculi. Metabolic bone and stone disease, E EC Nordin, A G Need, H A Morris. Churchill Livingston, London 1993; 249–310
   Google Scholar
• Smith L H. The medical aspects of urolithiasis: an overview. J Urol 1989; 141: 707–10
   PubMed Web of Science ®Google Scholar
• Watts R WE. Renal calculi and metabolic disorders of the kidney. Oxford textbook of medicine, D J Weatherall, J GG Ledingham, D A Warrell. Oxford University Press, Oxford 1983; 1881–1887
   Google Scholar
• Curhan G C, Willett W C, Rimm E B, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993; 328: 833–8
   PubMed Web of Science ®Google Scholar
• Asper R. Epidemiology and socioeconomic aspects of urolithiasis. Urol Res 1984; 2: 1–5
   Google Scholar
• Robertson W G. Urinary tract calculi. Metabolic bone and stone disease, B EC Nordin. Churchill Livingstone, Hong Kong 1984; 271–326
   Google Scholar
• Baker P W, Coyle P, Bais R, et al. Influence of season, age, and sex on renal stone formation in South Australia. Med J Aust 1993; 159: 390–2
   PubMed Web of Science ®Google Scholar
• Coe F L, Favus M J. Nephrolithiasis. The kidney, B M Brennor, F C Rector. W. B. Saunders Company, Philadelphia 1991; 1728–67
   Google Scholar
• Smith L H, Wilson D M, Goldfarb S, et al. Renal stones. Endocrinol Metab Clin North Am 1990; 19: 773–947
   PubMedGoogle Scholar
• Pyrah L N. Renal calculus. Springer-Verlag, Berlin 1979
   Google Scholar
• Su C J, Shevock P N, Khan S R, et al. Effect of magnesium on calcium oxalate urolithiasis. J Urol 1991; 145: 1092–5
   PubMedGoogle Scholar
• Rofe A M, Bais R, Conyers R AJ. The effect of dietary refined sugars and sugar alcohols on renal calcium oxalate deposition in ethylene glycol-treated rats. Food Chem Toxicol 1986; 24: 397–403
   PubMedGoogle Scholar
• Khan S R. Pathogenesis of oxalate urolithiasis: Lessons from experimental studies with rats. Am J Kidney Dis 1991; 17: 398–401
   PubMedGoogle Scholar
• Welshman S G, McGeowin M G. Urinary citrate excretion in stone-formers and normal controls. Br J Urol 1976; 48: 7–11
   PubMedGoogle Scholar
• Wong S YP, Slater S R, Evans R A, et al. Metabolic studies in kidney stone disease. Q J Med 1992; 299: 247–58
   Google Scholar
• Grases F, Conte A, Genestar C, et al. Inhibitors of calcium oxalate crystallization and urolithiasis. Urol Int 1992; 48: 409–14
   PubMedGoogle Scholar
• Grover P K, Ryall R L, Marshall V R. Effect of urate on calcium oxalate crystallization in human urine: Evidence for a promotory role of hyperuricosuria in urolithiasis. Clin Sci 1990; 79: 9–15
   Google Scholar
• Coe F L, Lawton R L, Goldstein R B, et al. Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc Soc Exp Biol Med 1975; 149: 926–9
   PubMedGoogle Scholar
• Smith L H. Idiopathic calcium oxalate urolithiasis. Endocrinol Metab Clin North Am 1990; 19: 937–47
   PubMedGoogle Scholar
• Pak C YC, Skurla C, Harvey J. Graphic display of urinary risk factors for renal stone formation. J Urol 1985; 134: 867–70
   PubMed Web of Science ®Google Scholar
• Coe F L, Favus M J. Disorders of bone and mineral metabolism. Raven Press, New York 1992
   Google Scholar
• Finlayson B. Physicochemical aspects of urolithiasis. Kidney Int 1978; 13: 344–60
   PubMed Web of Science ®Google Scholar
• Fleisch H. Inhibitors and promoters of stone formation. Kidney Int 1978; 13: 361–71
   PubMed Web of Science ®Google Scholar
• Bateson E M. Renal calculi and climate. Med J Aust 1973; 2: 111–3
   PubMedGoogle Scholar
• Robertson W G, Gallagher J C, Marchall D H, et al. Seasonal variation in urinary excretion of calcium. Br Med J 1974; 4: 436–7
   PubMed Web of Science ®Google Scholar
• Borghi L, Meschi T, Amato F, et al. Hot occupation and nephrolithiasis. J Urol 1993; 150: 1757–60
   PubMed Web of Science ®Google Scholar
• Finlayson B. Renal lithiasis in review. Urol Clin North Am 1974; 1: 181–212
   PubMedGoogle Scholar
• Ackermann D. Prophylaxis in idiopathic calcium urolithiasis. Urol Res 1990; 18: S37–40
   Google Scholar
• Pak C YC, Sakhaee K, Crowther C, et al. Evidence justifying a high fluid intake in treatment on nephrolithiasis. Ann Intern Med 1980; 93: 36–9
   PubMed Web of Science ®Google Scholar
• Cupisti A, Morelli E, Lupetti S, et al. Low urine citrate excretion as main risk factor for recurrent calcium oxalate nephrolithiasis in males. Nephron 1992; 61: 73–6
   PubMedGoogle Scholar
• Nicar M J, Skurla C, Sakhaee K, et al. Low urinary citrate excretion in nephrolithiasis. Urology 1983; 21: 8–14
   PubMed Web of Science ®Google Scholar
• Johansson G, Backman U, Danielson B G, et al. Magnesium metabolism in renal stone formers. Effects of therapy with magnesium hydroxide. Scand J Urol Nephrol 1980; 53: 125–30
   Google Scholar
• Tiselius H G. Oxalate and renal stone formation. Scand J Urol Nephrol 1980; 53: 135–46
   Google Scholar
• Edwards P, Nemat S, Rose G A. Effects of oral pyridoxine upon plasma and 24-hour urinary oxalate levels in normal subjects and stone formers with idiopathic hypercalciuria. Urol Res 1990; 18: 393–6
   PubMedGoogle Scholar
• Lucke H, Stange G, Murer H. Sulphate-ion/sodium-ion co-transport by brush-border membrane vesicles isolated from rat kidney cortex. Biochem J 1979; 182: 223–9
   PubMedGoogle Scholar
• Harris K S, Richardson K E. Glycolate in the diet and its conversion to urinary oxalate in the rat. Invest Urol 1980; 18: 106–9
   PubMedGoogle Scholar
• Balcke P, Zazgomik J, Sunder-Plassmann G, et al. Transient hyperoxaluria after ingestion of chocolate as a high risk factor for calcium oxalate calculi. Nephron 1989; 51: 32–4
   PubMedGoogle Scholar
• Laker M E. The clinical chemistry of oxalate metabolism. Adv Clin Chem 1983; 23: 259–97
   PubMedGoogle Scholar
• Williams A W, Wilson D M. Dietary intake, absorption, metabolism, and excretion of oxalate. Semin Nephrol 1990; 10: 2–8
   PubMedGoogle Scholar
• Conyers R AJ. Ascorbic acid intake, renal function, and urinary oxalate excretion. Aust NZJ Med 1985; 15: 353–5
   PubMedGoogle Scholar
• Gambardella R L, Richardson K E. The pathways of oxalate formation from phenylalanine, tyrosine, tryptophan and ascorbic acid in the rat. Biochim Biophys Acta 1977; 499: 156–68
   PubMedGoogle Scholar
• Urivetzky M, Kessaris D, Smith A D. Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis. J Urol 1992; 147: 1215–8
   PubMed Web of Science ®Google Scholar
• Winek C L, Shingleton D P, Shanor S P. Ethylene and diethylene glycol toxicity. Clin Toxicol 1978; 13: 297–324
   PubMed Web of Science ®Google Scholar
• Gessner P K, Parke D V, Williams R T. Studies in detoxification: the metabolism of 14C-labelled ethylene glycol. Biochem J 1961; 79: 482–9
   PubMed Web of Science ®Google Scholar
• Thomas D W, Hannett B, Chalmers A, et al. Oxalate excretion during carbohydrate infusions. Int J Vitam Res 1976; 15: 181–92
   Google Scholar
• Hannett B, Thomas D W, Chalmers A H, et al. Formation of oxalate in pyridoxine or thiamine deficient rats during intravenous xylitol infusion. J Nutr 1976; 107: 458–65
   Google Scholar
• Rofe A M, Thomas D W, Edwards R G, et al. Oxalate synthesis from xylitol: In vivo and in vitro studies. Biochem Med 1977; 18: 440–51
   PubMedGoogle Scholar
• Rofe A M, Conyers R AJ, Edwards J B. Oxalate excretion in rats injected with xylitol or glycolate: stimulated by phenobarbitone pre-treatment. AJEBAK 1979; 57: 171–6
   Google Scholar
• Rofe A M, James H M, Bais R, et al. The production of (14C) oxalate during the metabolism of 14C carbohydrates in isolated rat hepatocytes. AJEBAK 1980; 58: 103–16
   Google Scholar
• James H M, Bais R, Edwards J B, et al. Models for the metabolic production of oxalate from xylitol in humans: A role of fructokinase and aldolase. AJEBAK 1982; 60: 117–22
   Google Scholar
• James H M, Williams S G, Bais R, et al. The metabolic production of oxalate from xylitol: activity of transketolase, transaldolase, fructokinase and aldolase in liver, kidney, brain, heart and muscle in rat, mouse, guinea pig, rabbit and human. Int J Vitam Res 1985; 29: 29–46
   Google Scholar
• Bais R, James H M, Rofe A M, et al. The purification and properties of human liver ketohexokinase. A role for ketohexokinase and fructose-biphosphate aldolase in the metabolic production of oxalate from xylitol. Biochem J 1985; 230: 53–60
   PubMedGoogle Scholar
• Erickson S B, Cooper K, Broadus A E, et al. Oxalate absorption and postprandial urine super-saturation in an experimental human model of absorptive hypercalciuria. Clin Sci 1984; 67: 131–8
   Google Scholar
• Robertson W G, Peacock M. The cause of idiopathic calcium stone disease: Hypercalciuria or hyperoxaluria. Nephron 1980; 26: 105–10
   PubMed Web of Science ®Google Scholar
• Marshall R W, Cockran M, Hodgkinson A. Relationship between calcium and oxalic acid intake in the diet and their excretion in the urine of normal and renal-stone forming subjects. Clin Sci 1972; 43: 91–9
   PubMed Web of Science ®Google Scholar
• Brinkley L, McGuire J, Gregory J, et al. Bioavailability of oxalate in foods. Urology 1981; 17: 534–8
   PubMed Web of Science ®Google Scholar
• Berg W, Bother C, Pirlich W. Influence of magnesium on the absorption and excretion of calcium and oxalate ions. Eur Urol 1986; 12: 274–82
   PubMed Web of Science ®Google Scholar
• Hodgkinson A. Evidence of increased oxalate absorption in patients with calcium-containing renal stones. Clin Sci 1978; 54: 291–4
   Google Scholar
• Nakada T, Sasagawa I, Furuta K, et al. Effect of high calcium on urinary oxalate excretion in urinary stone formers. Eur Urol 1988; 15: 264–70
   PubMedGoogle Scholar
• Brown W W, Wolfson M. Diet as culprit or therapy. Med Clin North Am 1993; 77: 783–94
   PubMedGoogle Scholar
• Smith L H. Diet and hyperoxaluria in the syndrome of idiopathic calcium oxalate urolithiasis. Am J Kidney Dis 1991; 17: 370–5
   PubMedGoogle Scholar
• Rao P N, Prendville V, Buxton A, et al. Dietary management of urinary risk factors in renal stone formers. Br J Urol 1982; 54: 578–83
   PubMedGoogle Scholar
• Baggio B, Marchini F, Gambaro G, et al. Raised transmembrane oxalate flux in red blood cells in idiopathic calcium oxalate nephrolithiasis. Lancet 1984; 12–3
   PubMedGoogle Scholar
• Baggio B, Gambaro G, Marchini F, et al. An inheritable anomaly of red-cell oxalate transport in “primary” calcium nephrolithiasis correctable with diuretics. N Engl J Med 1986; 314: 599–604
   PubMed Web of Science ®Google Scholar
• Gambaro G, Baggio B. Idiopathic calcium oxalate nephrolithiasis: A cellular disease. Scanning Microsc 1992; 6: 247–54
   PubMedGoogle Scholar
• Baggio B, Gambaro G, Borsatti A, et al. Relation between band-3 red blood cell protein and transmembrane oxalate flux in stone formers. Lancet 1984; 223–4
   PubMedGoogle Scholar
• Baggio B, Marzaro G, Gambaro G, et al. Glycosaminoglycan content, oxalate self-exchange and protein phosphorylation in erythrocytes of patients with “idiopathic” calcium oxalate nephrolithiasis. Clin Sci 1990; 79: 113–6
   PubMed Web of Science ®Google Scholar
• Baggio B, Gambaro G, Marzaro G, et al. Effects of the oral administration of glycosaminoglycans on cellular abnormalities associated with idiopathic calcium oxalate nephrolithiasis. Eur J Clin Pharmacol 1991; 40: 237–40
   PubMed Web of Science ®Google Scholar
• Borsatti A. Calcium oxalate nephrolithiasis: defective oxalate transport. Kidney Int 1991; 39: 1283–98
   PubMed Web of Science ®Google Scholar
• Baggio B, Gambaro G, Marchini F, et al. Correction of erythrocyte abnormalities in idiopathic calcium-oxalate nephrolithiasis and reduction of urinary oxalate by oral glycosaminoglycans. Lancet 1991; 338: 403–5
   PubMedGoogle Scholar
• Gill H S, Rose A. Mild metabolic hyperoxaluria and its response to pyridoxine. Urol Int 1986; 41: 393–6
   PubMedGoogle Scholar
• Khan S R, Shevock P N, Hackett R L. Magnesium oxide administration and prevention of calcium oxalate nephrolithiasis. J Urol 1993; 149: 412–6
   PubMedGoogle Scholar
• Bais R, Rofe A M, Conyers R AJ. Investigations into the effect of glyoxylate decarboxylation and transamination on oxalate formation in the rat. Nephron 1991; 57: 460–9
   PubMedGoogle Scholar
• Bowyer R C, Brockis J G, McCulloch R K. Glycosaminoglycans as inhibitors of calcium oxalate crystal growth and aggregation. Clin Chim Acta 1979; 95: 23–8
   PubMedGoogle Scholar
• Fleisch H, Bisaz S. Isolation from urine of pyrophosphate a calcification inhibitor. Am J Physiol 1962; 203: 671–5
   PubMed Web of Science ®Google Scholar
• Meyer J L, Smith L H. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol 1975; 13: 36–9
   PubMedGoogle Scholar
• Kitamura T, Zerwekh J E, Pak C YC. Partial biochemical and physicochemical characterisation of organic macromolecules in urine from patients with renal stones and control subjects. Kidney Int 1982; 21: 379–86
   PubMedGoogle Scholar
• Zerwekh J E, Holt K, Pak C YC. Natural urinary macromolecular inhibitors: Attenuation of inhibitory activity by urate salts. Kidney Int 1983; 23: 838–41
   PubMed Web of Science ®Google Scholar
• Shorr E, Bernheim A R, Taussky H. The relation of uric acid excretion to the menstrual cycle and the steroidal reproductive hormones. Science 1942; 95: 606–7
   PubMedGoogle Scholar
• Abdulhadi M H, Hall P M, Streem S B. Can citrate therapy prevent nephrolithiasis?. Urology 1993; 41: 221–4
   PubMedGoogle Scholar
• Barcelo P, Servitge E, Rousaud A, et al. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 1993; 150: 1761–4
   PubMed Web of Science ®Google Scholar
• Tawashi R, Cousineau M, Denis G. Calcium oxalate crystal growth in normal urine: Role of contraceptive hormones. Urol Res 1984; 12: 7–9
   PubMedGoogle Scholar
• Pak C YC, Koenig K, Khan R, et al. Physicochemical action of potassium-magnesium citrate in nephrolithiasis. J Bone Miner Res 1992; 7: 281–5
   PubMedGoogle Scholar
• Herrmann U, Schwille P O, Schwarzlaender H, et al. Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium sodium citrate administered as short-, medium-and long-term to male stone patients. Urol Res 1992; 20: 347–53
   PubMedGoogle Scholar
• Drach G W, Springman K, Gottung B, et al. Effect of human urine on the aggregation of calcium oxalate crystals: Normal persons versus stone-formers. Urolithiasis and related clinical research, proceedings of the 5th international conference on urolithiasis. Plenum Press, New York 1985; 875–878
   Google Scholar
• Kok D J, Papapoulos S E, Bijvoet O LM. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers. Lancet 1986; 1056–8
   PubMedGoogle Scholar
• Smith L H, Wemess P G, Lee K E, et al. Inhibitors of crystal growth and aggregation in calcium urolithiasis. Clin Res 1979; 26: 727a
   Google Scholar
• Dent C E, Sutor D J. Presence or absence of inhibitor of calcium-oxalate crystal growth in urine of normals and of stone-formers. Lancet 1971; ii: 775–8
   Google Scholar
• Conte A C, Roca P, Genestar C, et al. Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects. Nephron 1989; 52: 162–5
   PubMedGoogle Scholar
• Grases F, Conte A, Coll R, et al. The role of hyperoxaluria in the formation of calcium oxalate urinary calculi, and its association with other biochemical measurements. Scand J Urol Nephrol 1990; 24: 211–3
   PubMedGoogle Scholar
• Grases F, Genestar C, March P, et al. Variations in the activity of urinary inhibitors in calcium oxalate urolithiasis. Br J Urol 1988; 62: 515–20
   PubMedGoogle Scholar
• Grases F, Genestar C, Conte A, et al. Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis. Br J Urol 1989; 64: 235–7
   PubMedGoogle Scholar
• Barilla D E, Notz C, Kennedy D, et al. Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias: effect of calcium and magnesium. Am J Med 1978; 64: 576–85
   Google Scholar
• Hammerstein G. Calcium oxalate and its solubility in the presence of inorganic salts, with special reference to the occurrence of oxalate. CR Lab Carlsberg 1929; 17: 83
   Google Scholar
• Kohri K, Garside J, Blacklock N J. The role of magnesium in calcium oxalate urolithiasis. Br J Urol 1988; 61: 107–12
   PubMedGoogle Scholar
• Li M K, Blacklock N J, Garside J. Effect of magnesium on calcium oxalate crystallization. J Urol 1985; 133: 123–8
   PubMed Web of Science ®Google Scholar
• Ryall R L, Hamett R H, Marshall V R. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 1981; 112: 349–56
   PubMed Web of Science ®Google Scholar
• Geigy Scientific Tables. 1981
   Google Scholar
• Batielle P, Pruna A, Leflon P, et al. Evidence for magnesium depletion in idiopathic hypercalciuria. Urolithiasis and related clinical research, proceedings of the 5th international conference on urolithiasis. Plenum Press, New York 1985; 323–6
   Google Scholar
• Drach G W, Gaines J, Donovan J. Magnesium metabolism related to calcium urolithiasis?. Urolithiasis and related clinical research, proceedings of the 5th international conference on urolithiasis. Plenum Press, New York 1985; 241–4
   Google Scholar
• Sato K, Akaike T, Kohno M, et al. Hydroxyl radical production by H2O2 plus Cu, Zn-super-oxide dismutase reflects the activity of free copper released from the oxidatively damaged enzyme. J Biol Chem 1992; 267: 25371–7
   PubMed Web of Science ®Google Scholar
• Tiselius H G, Larsson L. Studies on urine composition in patients with calcium oxalate stone disease. Urolithiasis and related clinical research, proceedings of the 5th international conference on urolithiasis. Plenum Press, New York 1985; 291–4
   Google Scholar
• Pak C YC, Nicar M J, Northcutt C. The definition of the mechanism of hypercalciuria is necessary for the treatment of recurrent stone formers. Contributions to nephrology. S. Karger, Basel 1982
   Google Scholar
• Pak C YC. Kidney stones: pathogenesis, diagnosis and therapy. Metabolic bone disease and clinically related disorders. W. B. Saunders Company, Philadelphia 1990
   Google Scholar
• Histome I, Tanaka Y, Kotake H, et al. Renal hyperuricemia due to enhanced tubular secretion of urate associated with urolithiasis: Successful treatment of urolithiasis by alkalinization of urine K+, Na+-citrate. Nephron 1993; 65: 578–82
   PubMedGoogle Scholar
• Bisaz S, Felix R, Neuman W, et al. Quantitative determination of inhibitors of calcium phosphate precipitation in whole urine. Miner Electrolyte Metab 1978; 1: 74
   Google Scholar
• Ryall R L, Harriett R M, Hibberd C M, et al. Urinary risk factors in calcium oxalate stone disease: Comparison of men and women. Br J Urol 1987; 60: 480–8
   PubMedGoogle Scholar
• Grover P K, Ryall R L, Marshall V R. Calcium oxalate crystallization in urine: role of urate and glycosaminoglycans. Kidney Int 1992; 41: 149–54
   PubMedGoogle Scholar
• Hwang T IS, Preminger G M, Poindexter J, et al. Urinary glycosaminoglycans in normal subjects and patients with stones. J Urol 1988; 139: 995–7
   PubMed Web of Science ®Google Scholar
• Martelli A, Marchesini B, Buli P, et al. Urinary excretion pattern of main glycosaminoglycans in stone formers and controls. Urolithiasis and related clinical research, proceedings of the 5th international conference on urolithiasis. Plenum Press, New York 1985; 355–8
   Google Scholar
• Coe F L. Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int 1978; 13: 418–26
   PubMed Web of Science ®Google Scholar
• Ettinger B. Does hyperuricosuria play a role in calcium oxalate lithiasis?. J Urol 1989; 141: 738–41
   PubMedGoogle Scholar
• Brockis J G, Bowyer R C, McCulloch R K. A review of possible roles of urates in calcium oxalate urolithiasis. Scand J Urol Nephrol 1980; 53: 179–82
   Google Scholar
• Shum D KY, Gohel M DI. Separate effects of urinary chondroitin sulphate and heparin sulphate on the crystallization of urinary calcium oxalate: Differences between stone formers and normal control subjects. Clin Sci 1993; 85: 33–9
   Google Scholar
• Hennequin C, Lalanne V, Daudon M, et al. A new approach to studying inhibitors of calcium oxalate crystal growth. Urol Res 1993; 21: 101–8
   PubMedGoogle Scholar
• Russell R GG, Edwards N A, Hodgkinson A. Urinary pyrophosphate and urolithiasis. Lancet 1964; 1: 1446
   Google Scholar
• Robertson W G, Peacock M, Nordin B EC. Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 1973; 43: 31–7
   PubMed Web of Science ®Google Scholar
• Grases F, Costa-Bauza A, March J G, et al. Artificial stimulation of renal stone formation. Nephron 1993; 65: 77–81
   PubMedGoogle Scholar
• Shirane Y, Kagawa S. Scanning electron microscopic study of the effect of citrate and pyrophosphate on calcium oxalate crystal morphology. J Urol 1993; 150: 1980–3
   PubMedGoogle Scholar
• Sharma S, Vaidyanathan S, Thind S K, et al. Urinary excretion of inorganic pyrophosphate by normal subjects and patients with renal calculi in northwestern India and the effects of diclofenac sodium upon urinary excretion of pyrophosphate in stone formers. Urol Int 1992; 48: 404–8
   PubMedGoogle Scholar
• Singh D P, Teotia M, Teotia S PS, et al. Urinary pyrophosphate excretion in stone formers. Indian J Med Res 1985; 82: 341–5
   PubMedGoogle Scholar
• Schwille P O, Rumenapf G, Wolfel G, et al. Urinary pyrophosphate in patients with recurrent calcium urolithiasis and in healthy controls: a reevaluation. J Urol 1988; 140: 239–45
   PubMedGoogle Scholar
• Russell R GG, Bisaz S, Fleisch H. The influence of orthophosphate on the renal handling of inorganic pyrophosphate in man and dog. Clin Sci Mol Med 1976; 51: 435–43
   PubMedGoogle Scholar
• Baumann J M, Ackermann D, Affolter B. The influence of hydroxyapatite and pyrophosphate on the formation product of calcium oxalate at different pH's. Urol Res 1989; 17: 153–5
   PubMedGoogle Scholar
• Meyer J L, Bergert J H, Smith L H. The epitaxially induced crystal growth of calcium oxalate by crystalline uric acid. Invest Urol 1976; 14: 115–9
   PubMedGoogle Scholar
• Gambaro G, Vincenti M, Marchini F, et al. Abnormal urate transport in erythrocytes of patients with idiopathic calcium nephrolithiasis: a possible link with hyperuricosuria. Clin Sci 1993; 85: 41–4
   Web of Science ®Google Scholar
• Bernstein M J. Consensus conference. Prevention and treatment of kidney stones. J Urol 1989; 141: 804–7
   PubMedGoogle Scholar
• Segura J W. The role of percutaneous surgery in renal and ureteral stone removal. J Urol 1989; 141: 780–1
   PubMedGoogle Scholar
• Kelley J M. Extracorporeal shock wave lithotripsy of urinary calculi. Theory, efficacy, and adverse effects. West J Med 1990; 153: 65–9
   PubMedGoogle Scholar
• Pak C YC. Role of medical prevention. J Urol 1989; 141: 798–801
   PubMed Web of Science ®Google Scholar
• Uribarri J, Oh M S, Carroll H J. The first kidney stone. Ann Intern Med 1989; 111: 1006–9
   PubMed Web of Science ®Google Scholar
• Lingeman J E, Woods J, Toth P D, et al. The role of lithotripsy and its side effects. J Urol 1989; 141: 793–7
   PubMed Web of Science ®Google Scholar
• Williams H E, Wandzilak T R. Oxalate synthesis, transport and the hyperoxaluric syndromes. J Urol 1989; 141: 742–7
   PubMed Web of Science ®Google Scholar
• Hodgkinson A, Zarembski P M. Oxalic acid metabolism in man: a review. Calc Tiss Res 1968; 2: 115–32
   PubMedGoogle Scholar
• Hagler L, Herman R H. Oxalate metabolism. Am J Clin Nutr 1973; 26: 758–65
   PubMed Web of Science ®Google Scholar
• Williams H E, Smith L H. Primary hyberoxaluria. The metabolic basis of inherited disease. McGraw-Hill Book Company, New York 1983
   Google Scholar
• Hodgkinson A. Oxalic acid in biology and medicine. Academic Press, London 1977
   Google Scholar
• Dean B M, Watts R WE, Westwick W J. The conversion of [l-13C]glycine and [2-13C]glycine to [13C]oxalate in primary hyperoxaluria: Evidence for the existence of more than one metabolic pathway from glycine to oxalate in man. Clin Sci 1968; 35: 325–35
   PubMed Web of Science ®Google Scholar
• Liao L L, Richardson K E. The metabolism of oxalate precursors in isolated perfused rat livers. Arch Biochem Biophys 1972; 153: 438–48
   PubMedGoogle Scholar
• Rofe A M, Chalmers A H, Edwards J B. [14C]Oxalate synthesis from [U-14C]glyoxylate and [l-14C]glyoxylate in isolated rat hepatocytes. Biochem Med 1976; 16: 277–83
   PubMedGoogle Scholar
• Rofe A M, James H M, Bais R, et al. Hepatic oxalate production: The role of hydroxypyruvate. Biochem Med Metab Biol 1986; 36: 141–50
   PubMedGoogle Scholar
• Wanders R JA, van Roermund C WT, Westra R, et al. Alanine glyoxylate aminotransferase and the urinary excretion of oxalate and glycolate in hyperoxaluria type 1 and the Zellweger syndrome. Clin Chim Acta 1987; 165: 311–9
   PubMed Web of Science ®Google Scholar
• Gibbs D A, Watts R WE. The action of pyridoxine in primary hyperoxaluria. Clin Sci 1970; 38: 277–86
   PubMed Web of Science ®Google Scholar
• Binder H J. Intestinal oxalate absorption. Gastroenterology 1974; 67: 441–6
   PubMed Web of Science ®Google Scholar
• Knickelbein R G, Dobbins J W. Sulphate and oxalate exchange for bicarbonate across the basolateral membrane of rabbit ileum. Am J Physiol 1990; 259: G807–13
   Google Scholar
• Knickelbein R G, Aronson P S, Dobbins J W. Substrate and inhibitor specificity of anion exchangers on the brush border membrane of rabbit ileum. J Membr Biol 1985; 88: 199–204
   PubMedGoogle Scholar
• Freel R W, Hatch M, Earnest D L, et al. Oxalate transport across the isolated rat colon. A reexamination. Biochem Biophys Res Commun 1980; 600: 838–43
   Google Scholar
• Hatch M, Freel R W, Goldner A M, et al. Oxalate and chloride absorption by the rabbit colon: Sensitivity to metabolic and anion transport inhibitors. Gut 1984; 25: 232
   PubMedGoogle Scholar
• Prenen J AC, Boer Dorhout P, Mees E J. Absorption of oxalate from oxalate rich food in man. Am J Clin Nutr 1984; 40: 1007–10
   PubMed Web of Science ®Google Scholar
• Zarembski P M, Hodgkinson A. The oxalic acid content of English diets. Br J Urol 1962; 16: 627–34
   Google Scholar
• Zarembski P M, Hodgkinson A. Some factors influencing the urinary excretion of oxalic acid in man. Clin Chim Acta 1969; 25: 1–10
   PubMed Web of Science ®Google Scholar
• Baggio B, Gambaro G, Favaro S, et al. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease. Nephron 1983; 35: 11–4
   PubMed Web of Science ®Google Scholar
• Fry D W, Richardson K E. Isolation and characterisation of glycolic acid dehydrogenase from human liver. Biochim Biophys Acta 1979; 567: 482–91
   PubMedGoogle Scholar
• Yanagawa M, Maeda-Nakai E, Yamakawa K, et al. The formation of oxalate from glycolate in rat and human liver. Biochim Biophys Acta 1990; 1036: 24–33
   PubMedGoogle Scholar
• Chalmers A H, Cowley D M, McWhinney B C. Stability of ascorbate in urine: relevance to analyses for ascorbate and oxalate. Clin Chem 1985; 31: 1703–5
   PubMedGoogle Scholar
• Chalmers A H, Cowley D M, Brown J M. A possible etiological role for ascorbate in calculi formation. Clin Chem 1986; 32: 333–6
   PubMedGoogle Scholar
• Schmidt K H, Hagmaier V, Hornig D H, et al. Urinary oxalate excretion after large intakes of ascorbic acid in man. Am J Clin Nutr 1981; 34: 305–11
   PubMed Web of Science ®Google Scholar
• Atkins G L, Dean B M, Griffin W J, et al. Quantitative aspects of ascorbic acid metabolism in man. J Biol Chem 1964; 239: 2975–80
   PubMed Web of Science ®Google Scholar
• Hellman L, Burns J J. Metabolism of (L)-ascorbic acid 1-14C in man. J Biol Chem 1958; 230: 923–30
   PubMed Web of Science ®Google Scholar
• Baker E M, Saari J C, Tolbert B M. Ascorbic acid metabolism in man. Am J Clin Nutr 1966; 19: 371–8
   PubMed Web of Science ®Google Scholar
• Rivers J M. Safety of high-level vitamin C ingestion. Ann NY Acad Sci 1987; 498: 445–54
   PubMed Web of Science ®Google Scholar
• Butz M, Kaiser M, Fitzner R. Enhancement of urinary oxalate excretion by vitamin C—fact or artifact?. Urolithiasis, proceedings of the 7th international conference on urolithiasis. Plenum Press, New York 1984; 133–5
   Google Scholar
• Kallner A, Hartmann D, Hornig D. Steady-state turnover and body pool of ascorbic acid in man. Am J Clin Nutr 1979; 32: 530–9
   PubMed Web of Science ®Google Scholar
• Banay M, Dimant E. On the metabolism of L-ascorbic acid in the scrbutic guinea-pig. Biochim Biophys Acta 1962; 59: 313–9
   Google Scholar
• Curtin C O, King C G. The metabolism of ascorbic acid-1-14C and oxalic acid-14C in the rat. J Biol Chem 1955; 216: 539–48
   PubMedGoogle Scholar
• Baker E M, Sauberlich H E, Wolfskill S J, et al. Tracer studies of vitamin C utilisation in men: Metabolism of D-glucuronolactone-6-14C, D-glucuronic-6-14C acid and L-ascorbic-1-14C acid. Proc Soc Exp Biol Med 1962; 109: 737–41
   Google Scholar
• Farinelli M P, Richardson K E. Oxalate synthesis from [l-14C]glycolate and [l-14C]glyoxylate in the hepatectomized rat. Biochim Biophys Acta 1983; 757: 8–14
   PubMedGoogle Scholar
• Takiguchi H, Furuyama S, Shimazono N. Urinary oxalic excretion by man following ingestion of large amounts of ascorbic acid. J Vitaminol 1966; 12: 307–12
   Google Scholar
• Tiselius H G, Almgard L E. The diurnal urinary excretion of oxalate and the effect of pyridoxine and ascorbate on oxalate excretion. Eur Urol 1977; 3: 14–46
   Google Scholar
• Lamden M P, Chrystowski G A. Urinary oxalate excretion by man following ascorbic acid ingestion. Proc Soc Exp Biol Med 1954; 85: 190–2
   PubMedGoogle Scholar
• Takenouchi K, Aso K, Kawase K, et al. On the metabolites of ascorbic acid, especially oxalic acid, eliminated in urine following the administration of large amounts of ascorbic acid. J Vitaminol 1966; 12: 49–58
   PubMedGoogle Scholar
• Wandzilak T R, D'Andre S D, Davis P A, et al. Effect of high-dose vitamin C on urinary oxalate levels. J Urol 1994; 151: 834–7
   PubMed Web of Science ®Google Scholar
• Singh P P, Kiran R, Pendse A K, et al. Ascorbic acid is an abettor in calcium urolithiasis: an experimental study. Scanning Microsc 1993; 7: 1041–8
   PubMedGoogle Scholar
• Bais R, Rofe A M, Conyers R AJ. Inhibition of endogenous oxalate production: biochemical consideration of the role of glycolate oxidase and lactate dehydrogenase. Clin Sci 1989; 76: 303–9
   Google Scholar
• Romano M, Cerra M. The action of crystalline lactate dehydrogenase from rabbit on glyoxylate. Biochim Biophys Acta 1969; 177: 421–6
   PubMedGoogle Scholar
• Gibbs D A, Watts R WE. An investigation of the possible role of xanthine oxidase in the oxidation of glycolate to oxalate. Clin Sci 1966; 31: 285–97
   PubMedGoogle Scholar
• Gibbs D A, Watts R WE. The identification of the enzymes that catalyse the oxidation of glyoxylate to oxalate in the 100000 g supernatant fraction of human hyperoxaluric and control liver and heart tissue. Clin Sci 1973; 44: 227–41
   PubMedGoogle Scholar
• Warren W A. Catalysis of both oxidation and reduction of glyoxylate by pig heart lactate dehydrogenase isoenzyme 1. J Biol Chem 1970; 245: 1675–81
   PubMed Web of Science ®Google Scholar
• Schuman M, Massey V. Purification and characterisation of glycolic acid oxidase from pig liver. Biochim Biophys Acta 1971; 227: 500–20
   PubMedGoogle Scholar
• Tateishi N, Higashi T, Naruse A, et al. Rat liver glutathione: possible role as a reservoir of cysteine. J Nutr 1977; 107: 51–60
   PubMed Web of Science ®Google Scholar
• Asker H, Davies D. Purification of rat liver enzymes involved in the oxidation of glyoxylate. Biochim Biophys Acta 1983; 761: 103–8
   PubMedGoogle Scholar
• Gibbs D A, Hauschildt S, Watts R WE. Glyoxylate oxidation in rat liver and kidney. J Biochem 1977; 82: 221–30
   PubMedGoogle Scholar
• Rofe A M, Edwards J B. Oxalate synthesis in isolated rat hepatocytes: the effects of hydroxypyruvate and amino-oxyacetate. Biochem Med 1978; 20: 323–35
   PubMedGoogle Scholar
• Smith L HJ, Bauer R L, Williams H E. Oxalate and glycolate synthesis by hemic cells. J Lab Clin Med 1971; 78: 245–54
   PubMedGoogle Scholar
• Williamson D H, Lund P, Krebs H A. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J 1967; 103: 514–27
   PubMed Web of Science ®Google Scholar
• Richardson K E, Tolbert N E. Oxidation of glyoxylic acid to oxalic acid by glycolic acid oxidase. J Biol Chem 1961; 236: 1280–4
   PubMed Web of Science ®Google Scholar
• Liao L L, Richardson K E. The inhibition of oxalate biosynthesis in isolated perfused rat liver by DL-phenyllactate and n-heptanoate. Arch Biochem Biophys 1973; 154: 68–75
   PubMedGoogle Scholar
• Gambardella R L, Richardson K E. The formation of oxalate from hydroxypyruvate, serine, glycolate and glyoxylate in the rat. Biochim Biophys Acta 1978; 544: 315–28
   PubMedGoogle Scholar
• Richardson K E. Effect of testosterone on the glycolic acid oxidase levels in male and female rat liver. Endocrinology 1964; 74: 128–32
   PubMed Web of Science ®Google Scholar
• Richardson K E. Endogenous oxalate synthesis in male and female rats. Toxicol Appl Pharmacol 1965; 7: 507–15
   PubMed Web of Science ®Google Scholar
• Silbergeld S, Carter H E. Toxicity of glycolic acid in male and female rats. Arch Biochem Biophys 1959; 84: 183–7
   PubMedGoogle Scholar
• Liao L L, Richardson K E. The synthesis of oxalate from hydroxypyruvate by isolated perfused rat livers. The mechanism of hyperoxaluria in L-glyceric aciduria. Biochim Biophys Acta 1978; 538: 76–86
   PubMedGoogle Scholar
• Baker P W, Bais R, Rofe A M. Formation of the (L)-cysteine-glyoxylate adduct is the mechanism by which (L)-cysteine reduces oxalate production from glycolate. Biochem J 1994; 302: 753–757
   PubMedGoogle Scholar
• Cook D A, Henderson L M. The formation of oxalic acid from the side chain of aromatic amino acids in the rat. Biochim Biophys Acta 1969; 184: 404–11
   PubMedGoogle Scholar
• Varalakshmi P, Richardson K E. The effects of vitamin B6 deficiency and hepatectomy on the synthesis of oxalate from glycolate in the rat. Biochim Biophys Acta 1983; 757: 1–7
   PubMedGoogle Scholar
• Weinhouse S, Friedmann B. Metabolism of labeled 2-carbon acids in the intact rat. J Biol Chem 1951; 191: 707–17
   PubMedGoogle Scholar
• Thompson J S, Richardson K E. Isolation and characterization of an L-alanine:glyoxylate aminotransferase from human liver. J Biol Chem 1967; 242: 3614–9
   PubMed Web of Science ®Google Scholar
• Neims A H, Hellermann L. Specificity of the D-amino acid oxidase in relation to glycine oxidase activity. J Biol Chem 1962; 237: PC976
   PubMedGoogle Scholar
• Ratner S, Nocito V, Green D E. Glycine oxidase. J Biol Chem 1944; 152: 119–25
   Google Scholar
• Cammarata P S, Cohen P P. The scope of the transamination reaction in animal tissues. J Biol Chem 1950; 187: 439
   PubMed Web of Science ®Google Scholar
• Metzler D E, Olivard J, Snell E E. Transamination of pyridoxamine and amino acids with glyoxylic acid. J Am Chem Soc 1957; 76: 644–9
   Google Scholar
• Crawhill J C. Conversion of glycine to oxalate in a normal subject. Lancet 1959; 2: 810
   PubMedGoogle Scholar
• Maxwell E S, Topper Y J. Steroid-sensitive aldehyde dehydrogenase from rabbit liver. J Biol Chem 1961; 236: 1032–7
   PubMedGoogle Scholar
• Weinhouse S. The synthesis and degradation of glycine. Symposium on amino acid metabolism. The Johns Hopkins Press, Baltimore 1955, McCollum Pratt Institute contribution no. 105
   Google Scholar
• Noguchi T, Takada Y. Peroxisomal localization of alanine:glyoxylate aminotransferase in human liver. Arch Biochem Biophys 1979; 196: 645–7
   PubMedGoogle Scholar
• Noguchi T, Okuno E, Takada Y, et al. Characteristics of hepatic alanine-glyoxylate aminotransferase in different mammalian species. Biochem J 1978; 169: 113–22
   PubMedGoogle Scholar
• Rowsell E V, Snell K, Carnie J A, et al. The subcellular distribution of rat liver L-alanine-glyoxylate aminotransferase in relation to a pathway for glucose formation involving glyoxylate. Biochem J 1972; 127: 155–65
   PubMed Web of Science ®Google Scholar
• Sharma S, Sidhu H, Narula R, et al. Comparative studies on the effect of vitamin A, B, and B6 deficiency on oxalate metabolism in male rats. Ann Nutr Metab 1990; 34: 104–11
   PubMed Web of Science ®Google Scholar
• Danpure C J, Jennings P R. Further studies on the activity and subcellular distribution of alanine:glyoxylate aminotransferase in the livers of patients with primary hyperoxaluria type 1. Clin Sci 1988; 75: 315–22
   Google Scholar
• Purdue P E, Allsop J, Isaya G. et al. Mistargeting of peroxisomal L-alanine:glyoxylate aminotransferase to mitochondria in primary hyperoxaluria patients depends upon activation of a cryptic mitochondrial targeting sequence by a point of mutation. Proc Natl Acad Sci USA 1991; 88: 10900–4
   PubMed Web of Science ®Google Scholar
• O'Fallon J V, Brosemer R W. Cellular localization of α-ketoglutarate:glyoxylate carboligase in rat tissues. Biochim. Biophys Acta 1977; 499: 321–8
   PubMedGoogle Scholar
• Stewart C B, Grammer J, Brosemer R W. Thiamine deficiency and glyoxylic acid. Ann Nutr Metab 1981; 25: 289–98
   PubMedGoogle Scholar
• Chow F C, Hamar D W, Boulay J P, et al. Prevention of oxalate urolithiasis by some compounds. Invest Urol 1978; 15: 493–5
   PubMedGoogle Scholar
• Rooney C S, Randall W C, Streeter K B, et al. Inhibitors of glycolic acid oxidase. 4-Substituted 3-hydroxy-l-H-pyrrole-2,5-dione derivatives. J Med Chem 1983; 26: 700–14
   PubMedGoogle Scholar
• Zinsser H H, Karp F. How to diminish endogenous oxalate excretion. Invest Urol 1973; 10: 249–52
   PubMedGoogle Scholar
• Talware H S, Madiraju V S, Murthy S R, et al. Preliminary report. Normalization of urinary oxalate by taurine in glycolate-fed rats. Metabolism 1985; 34: 97–100
   PubMedGoogle Scholar
• Sharma V, Thind S K, Nath R. Effect of sex hormones and glycollate feeding on rat liver glycollate oxidase. Urol Res 1984; 12: 76–80
   Google Scholar
• O'Keeffe C M, Cies L, Smith L H. Inhibition of oxalate biosynthesis: In vivo studies in the rat. Biochem Med 1973; 7: 299–307
   PubMedGoogle Scholar
• Selvam G S, Varalakshmi P. Effect of different isomers of tartrate on oxalate metabolism in hyperoxaluric rats. Med Sci Res 1989; 17: 685–7
   Google Scholar
• Selvam G S, Varalakshmi P. Role of L(+)-tartrate in experimental calcium oxalate urolithiasis. Med Sci Res 1990; 18: 313–5
   Google Scholar
• Bais R, Rofe A M, Conyers R AJ. The inhibition of metabolic oxalate production by sulphydryl compounds. J Urol 1991; 145: 1302–5
   PubMedGoogle Scholar
• Baker P W, Bais R, Rofe A M. The efficacy of (L)-2-oxothiazolidine-4-carboxylate (OTC) and (t)-cysteine in reducing urinary oxalate excretion. J Urol November, 1994, (in press)
   Google Scholar
• Sharma V, Schwille P O. Oxalate production form glyoxylate by lactate dehydrogenase in vitro: Inhibition by reduced glutathione, cysteine and cysteamine. Biochem Int 1992; 27: 431–8
   PubMedGoogle Scholar
• Sharma V, Schwille P O. Sulphite inhibits oxalate production from glycolate and glyoxylate in vitro and from dichloroacetate infused IV into male rats. Biochem Med Metab Biol 1993; 49: 265–9
   PubMedGoogle Scholar
• Schubert M P. Reactions of semimercaptals with amino compounds. J Biol Chem 1936; 121: 539–48
   Google Scholar
• Schmolka I R, Spoerri P E. Thiazolidine chemistry. II. The preparation of 2-substituted thiazolidine-4-carboxylic acids. Org Chem 1957; 22: 943–6
   Google Scholar
• Ratner S, Clarke H T. The action of formaldehyde upon cysteine. J Am Chem Soc 1937; 59: 200–6
   Google Scholar
• Bums C L, Main D E, Buckthal D J, et al. Thiazolidine-2-carboxylate derivatives formed from glyoxylate and L-cysteinylglycine as possible physiological substrates for D-aspartate oxidase. Biochem Biophys Res Commun 1984; 125: 1039–45
   PubMedGoogle Scholar
• Hamilton G A. Peroxisomal oxidases and suggestions for the mechanism of action of insulin and other hormones. Adv Enzymol 1985; 57: 85–178
   PubMedGoogle Scholar
• Venkatesan P P, Hamilton G A. The nonenzymatic hydrolysis of thiazolidine-2-carboxylate: the product of the suspected physiological reaction catalyzed by D-amino acid oxidase. Bioorg Chem 1986; 14: 392–404
   Google Scholar
• Pesek J J, Frost J H. Decomposition of thiazolidines in acidic and basic solution. Tetrahedron 1975; 31: 907–13
   Google Scholar
• Skorczynski S S, Hamilton G A. Oxalyl thioesters and N-oxalylcysteine are normal mammalian metabolites. Biochem Biophys Res Commun 1986; 141: 1051–7
   PubMedGoogle Scholar
• Alary J, Carrera G, De Saint Blanquat G, et al. Reversed-phase ion-pair high-performance liquid chromatographic determination of 2-carboxythiazolidine-4-carboxylic acid in plasma. J Chromatogr 1989; 496: 485–92
   PubMedGoogle Scholar
• Lamboeuf Y, De Saint Blanquat G, Roumec C, et al. Impairment of mitochondrial membrane by ethanol and protective effect of a thiazolidine compound in in vitro and in vivo experiments. Food Additive Contam 1990; 7: S138–41
   PubMed Web of Science ®Google Scholar
• Saigot T. Interet du tiadilon en pathologic hepatobiliaire. MCD 1979; 8: 575–6
   Google Scholar
• Raymond N. Interet de l'utilisation en gastro-enterologie d'un hepatotrope original, le tidiacicate d'arginine. MCD 1981; 10: 181–4
   Google Scholar
• Parkinson I S, Channon S M, Tomson C RV, et al. The determination of plasma oxalate concentrations using an enzyme/bioluminescent assay. II. Co-immobilisation of bioluminescent enzymes and studies of In vitro oxalogenesis. Clin Chim Acta 1989; 179: 97–108
   PubMed Web of Science ®Google Scholar
• Schwille P O, Manoharan M, Rumenapf G, et al. Oxalate measurement in the picomole range by ion chromatography: Values in fasting plasma and urine of controls and patients with idiopathic calcium urolithiasis. J Clin Chem Clin Biochem 1989; 27: 87–96
   PubMedGoogle Scholar
• Crider Q E, Curran D F. Simplified method for enzymatic urine oxalate assay. Clin Biochem 1984; 17: 351–5
   PubMed Web of Science ®Google Scholar
• Wilson D M, Liedtke R R. Modified enzyme based colourimetric assay of urinary and plasma oxalate with improved sensitivity and no ascorbate interference: reference values and sample handling procedures. Clin Chem 1991; 37: 1229–35
   PubMed Web of Science ®Google Scholar
• Munoz Leyva J A, Hernandez Artiga M P, Aragon Mendez M M, et al. Atomic absorption and UV-VIS absorption spectrophotometric determination of oxalate in urine by ligand exchange extraction. Clin Chim Acta 1990; 195: 47–56
   PubMedGoogle Scholar
• Berckmans R J, Boer P. An inexpensive method for sensitive enzymatic determination of oxalate in urine and plasma. Clin Chem 1988; 34: 1451–5
   PubMed Web of Science ®Google Scholar
• Coyle P C, Rofe A M, Renfeng F. Improved urinary oxalate method for a centrifugal analyser. Clin Chem 1989; 35: 1806
   PubMedGoogle Scholar
• Potezny N, Bais R, O'Loughlin P D, et al. Urinary oxalate determination by use of immobilized oxaiate oxidase in a continuous-flow system. Clin Chem 1983; 29: 827–30
   Google Scholar
• Fry I DR, Starkey B J. The determination of oxalate in urine and plasma by high performance liquid chromatography. Ann Clin Biochem 1991; 28: 581–7
   PubMedGoogle Scholar
• Goldsack K, Ginman R FA, Wright J M. Direct determination of urinary oxalate by a continuous flow method. Med Lab Sci 1990; 47: 73–9
   PubMedGoogle Scholar
• Li M G, Madappally M M. Rapid enzymatic determination of urinary oxalate. Clin Chem 1989; 35: 2330–3
   PubMed Web of Science ®Google Scholar
• Sharma S, Nath R, Thind S K. Recent advances in measurement of oxalate in biological materials. Scanning Microsc 1993; 7: 431–41
   PubMedGoogle Scholar
• Costello J, Landwehr D M. Determination of oxalate concentration in blood. Clin Chem 1988; 34: 1540–4
   PubMed Web of Science ®Google Scholar
• Hatch M, Bourke E, Costello J. New enzymatic method for serum oxalate determination. Clin Chem 1977; 23: 76–8
   PubMedGoogle Scholar
• Hatch M. Spectrophotometric determination of oxalate in whole blood. Clin Chim Acta 1990; 193: 199–202
   PubMedGoogle Scholar
• Allen L C, Kadijevic L, Romaschin A D. An enzymatic method for oxalate automated with the cobas fara centrifugal analyzer. Clin Chem 1989; 35: 2098–100
   PubMed Web of Science ®Google Scholar
• Laker M F, Hofmann A F, Meeuse B JD. Spectrophotometric determination of urinary oxalate with oxalate oxidase prepared from moss. Clin Chem 1980; 26: 827–30
   PubMed Web of Science ®Google Scholar
• Strauss E, Meerkins M, Moshides J. Convenient urine oxalate assay with an oxalate oxidase reagent and a centrifugal analyzer. Clin Chem 1987; 33: 2301
   PubMedGoogle Scholar
• Arlington C J, Chalmers A H. Gas chromatographic estimation of urinary oxalate and its comparison with a colorimetrio method. Clin Chem 1979; 25: 1993–6
   PubMedGoogle Scholar
• Yanagawa M, Ohkawa H, Tada S. The determination of urinary oxalate by gas chromatography. J Urol 1983; 129: 1163–5
   PubMedGoogle Scholar
• Schwendtner N, Achilles W, Engelhardt W, et al. Determination of urinary oxalate by isotachophoresis, practical improvement and critical evaluation. J Clin Chem Clin Biochem 1982; 20: 833–6
   PubMedGoogle Scholar
• Tschope W, Ritz E. Isotachophoretic determination of oxalate in unprocessed urine. Urolithiasis, clinical and basic research, L H Smith, W G Robertson, B Findlayson. Plenum Press, New York 1981; 951–75
   Google Scholar
• Lopez M, Tuchman M, Scheinman J T. Capillary gas chromatography measurement of oxalate in plasma and urine. Kidney Int 1985; 28: 82–4
   PubMedGoogle Scholar
• Pal Singh R AJ, Nancollas G H. Determination of phosphate, sulfate and oxalate in urine by ion chromatography. J Chromatogr 1988; 433: 373–6
   PubMedGoogle Scholar
• Prenen J AC, Peter B L. Urinary oxalate excretion determined by isotope dilution and indirect colorimetry. Clin Chim Acta 1983; 127: 251–61
   PubMedGoogle Scholar
• France N C, Holland P T, McGhie T K, et al. Measurement of plasma oxalate by capillary gas chromatography and its validation by isotope dilution mass spectrometry. J Chromatogr 1988; 433: 1–7
   PubMedGoogle Scholar
• Hagen L, Walker V R, Sutton R AL. Plasma and urinary oxalate and glycolate in healthy subjects. Clin Chem 1993; 39: 134–8
   PubMed Web of Science ®Google Scholar
• Wandzilak T R, D'Andre S D, Davis P A, et al. Effect of high dose vitamin C on urinary oxalate levels. J Urol 1994; 151: 834–7
   PubMed Web of Science ®Google Scholar
• Larsson L, Libert B, Asperud M. Determination of urinary oxalate by reversed-phase ion-pair high performance liquid chromatography. Clin Chem 1982; 28: 2272–4
   PubMed Web of Science ®Google Scholar
• Wildman B J, Jackson P E, Jones W R, et al. Analysis of anion constituents of urine by inorganic capillary electrophoresis. J Chromatogr 1991; 546: 459–66
   PubMed Web of Science ®Google Scholar
• Huggins T G, Henion J D. Capillary electrophoresis/mass spectrometry determination of inorganic ions spray-sheath flow interface. Electrophoresis 1993; 14: 531–9
   PubMedGoogle Scholar
• Homig D H, Moser U. The safety of high vitamin C intakes in man, C Vitamin. Applied Science Publishers, London 1981, (ascorbic acid)
   Google Scholar
• Herbert V. The antioxidant supplement myth. Am J Clin Nutr 1994; 60: 157–8
   PubMed Web of Science ®Google Scholar
• Inamdar K V, Raghavan K G, Pradhan D S. Five treatment procedures evaluated for the elimination of ascorbate interference in the enzymatic determination of urinary oxalate. Clin Chem 1991; 37: 864–8
   PubMedGoogle Scholar
• Petrarulo M, Marangella M, Bianco O, et al. Preventing ascorbate interference in ion-chro-matographic determinations of urinary oxalate: four methods compared. Clin Chem 1990; 36: 1642–5
   PubMed Web of Science ®Google Scholar